Skip to content
Link copied！

太平洋醫材股份有限公司 2025 Sustainability Report

Verified by a third party

Download

Share

  • Reporting Year：2025

  • Disclosure Period：2025/01/01 ~ 2025/12/31

  • Industry：生技醫療業

  • Verification Agency：台灣檢驗科技股份有限公司

  • Verification Standards：GRI準則

Report summary

  • This page summarizes the 2025 sustainability report and ESG report PDF source for 太平洋醫材股份有限公司 (4126).
  • The reporting period is 2025/01/01 to 2025/12/31, in the 生技醫療業 industry.
  • third-party information includes verification body 台灣檢驗科技股份有限公司; this can be used to review report verification, assurance, and disclosure standards.
  • Compare public disclosure approaches across prior-year and peer reports. Your company’s actual disclosures must still be based on its own data and supporting evidence.

Report details

Company
太平洋醫材股份有限公司（4126）
Reporting Year
2025
Disclosure Period
2025/01/01 to 2025/12/31
Industry
生技醫療業
Third-party information
third-party information includes verification body 台灣檢驗科技股份有限公司
PDF source
The original ESG report PDF can be downloaded or opened from this page

2025 ESG Metrics and Industry Comparison

Greenhouse Gas Emissions

Scope 1 Emissions (Tons CO2e)
351
Reporting Boundary：已完成母公司
Verification：是
Scope 2 Emissions (Tons CO2e)
5,020
Reporting Boundary：已完成母公司
Verification：是
Scope 3 Emissions (Tons CO2e)
1,244
Reporting Boundary：已完成母公司
Verification：是

Energy Management

Renewable Energy Share
3.9%
Reporting Boundary：全公司
Verification：Not disclosed
Ranked 3 among 18 companies in the same industry (percentile 88).

Water Management

Water Use (Metric Tons)
62,821
Reporting Boundary：全公司
Verification：Not disclosed

Board of Directors

Board Seats (Including Independent Directors)
7
Independent Director Seats
4
Female Director Ratio
28.6%
Ranked 33 among 96 companies in the same industry (percentile 62).
Board Meeting Attendance Rate
100%
Ranked 1 among 96 companies in the same industry (percentile 74).
Independent Director Ratio
57.1%
Ranked 2 among 96 companies in the same industry (percentile 85).

Source: Taiwan Stock Exchange / Taipei Exchange, Corporate ESG Disclosure Summary (2025), under the Open Government Data License, version 1.0. Open Government Data License, Version 1.0

How to use this report

  • Compare how 太平洋醫材股份有限公司 structured 生技醫療業 sustainability report chapters and material topics in 2025.
  • Confirm the reporting period, third-party verification or assurance information, and downloadable ESG report PDF source.
  • Mark public disclosures and original page numbers that can be referenced as research materials for planning chapters and indicators for your own company.

Reports from the Same Industry

How can this public report be used as a reference?

Compare chapter structures, metrics, and public disclosure approaches, then check the original page for context. A peer’s disclosure is not evidence about your company; use your own data and supporting documents for actual disclosures.

Plan your own reporting process with Syber Check my report View Syber reporting workflow
Check report Build report